1957 - 2007: 50th anniversary of interferon discovery!

At this occasion, an international one-day meeting, entitled: "From Discovery to Clinical Applications" was organized in the City Hall of Paris on the 30th of April, 2007.

Around 250 scientists (Europe and USA) attended the meeting, mainly coming from institutions (INSERM, Pasteur Institute, Institut Curie, CNRS…).

For this celebration, the co-discoverer of Interferon (Isaacs & Lindenmann, 1957), Prof. Jean Lindenmann himself, openned the meeting and high level lectures were then given on mechanism of action of IFNs, their use in cancer, their role in viral or non viral infections, in leishmaniasis, their clinical use in hepatitis & multiple sclerosis.

 

 

 

 


Welcome to Vetinterferon

 

  

This is an information platform on interferons and their use in small animal medicine.
The aim of this site is to enhance the knowledge on interferons by providing scientific references, field reports  and general information.

  


« Scientific references » are articles or congress abstracts published on interferons related to veterinary medicine. They cover different aspects that can be useful to the veterinary profession.

« Field reports » contain clinical cases that were published by practitioners who experienced the use of interferons in different areas. They are briefly reported to provide helpful information in practice.

All these data are regularly updated.
 

  

 

   

  

   

  

 

Recent updates
rHuIFN alpha-2b & rFeIFN-omega on FHV replication
At some of the higher concentrations, the antiviral effect of rFeIFN-omega was greater than the antiviral effect of rHuIFN-alpha2b. Reduction in plaque size appeared to be a good indicator of the antiviral activity of interferon against FHV-1.
more...
rFeIFN-omega in refractory FCGS
After unsuccessful initial treatment by extraction of all premolars and molars, the condition of the cat resolved within 6 weeks of treatment with FeIFN-omega
more...
rFeIFN-omega in feline fibrosarcoma
rFeIFN-omega should be considered as a potential therapy in the treatment of feline fibrosarcoma and should be tested in a prospective placebo-controlled study.
more...
rFeIFN-omega in conjunctival & white blood cells
Results indicate that Mx protein expression depends on the dose of rFeIFN-omega, site of administration, and cell type.
more...